abstract |
The invention relates to immunostimulatory oligonucleotides comprising the sequence TCGTCGTTTTACGGCGCCGTTGCCG (SEQ ID NO:44) and to their use in medicine, particularly in the treatment of cancer. The oligonucleotides are useful as adjuvants in vaccination. They are also useful for inducing an immune response and inducing type I interferon (IFN) expression. |